Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 69Breast 6Genitourinary 2Gastrointestinal 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Thrombocytopenia 1Recurrence 1Ovarian Neoplasms 1Neutropenia 1Fallopian Tube Neoplasms 1Anemia 1

Interventions

olaparib 5stinging nettle lectin 1peppermint oil 1niraparib 1liposomal doxorubicin 1ferrous fumarate 1apixaban 1angiotensin I (1-7) 1Tretinoin 1Trabectedin 1Surveys and Questionnaires 1Rivaroxaban 1Pharmacokinetics 1Heparin, Low-Molecular-Weight 1Genetic Counseling 1Gemcitabine 1Ferric Oxide, Saccharated 1Epoetin Alfa 1Demography 1Data Collection 1Darbepoetin alfa 1Counseling 1Cognitive Behavioral Therapy 1Carboplatin 1Aspirin 1Anticoagulants 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ovarian Neoplasms × niraparib × Classical hematology × Clear all
NCT03891576 2025-01-17

Newton

Mario Negri Institute for Pharmacological Research

Phase 2 Terminated
83 enrolled
Classical hematologyGynecologic

Anemia, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms, Recurrence, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡